Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3-kinase/protein kinase B inhibitors
- PMID: 15833867
- DOI: 10.1158/0008-5472.CAN-04-3640
Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3-kinase/protein kinase B inhibitors
Abstract
The mammalian target of rapamycin (mTOR) is a downstream effector of the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway and a central modulator of cell proliferation in malignant gliomas. Therefore, the targeting of mTOR signaling is considered a promising therapy for malignant gliomas. However, the mechanisms underlying the cytotoxic effects of a selective mTOR inhibitor, rapamycin, on malignant glioma cells are poorly understood. The purpose of this study was thus to elucidate how rapamycin exerts its cytotoxic effects on malignant glioma cells. We showed that rapamycin induced autophagy but not apoptosis in rapamycin-sensitive malignant glioma U87-MG and T98G cells by inhibiting the function of mTOR. In contrast, in rapamycin-resistant U373-MG cells, the inhibitory effect of rapamycin was minor, although the phosphorylation of p70S6 kinase, a molecule downstream of mTOR, was remarkably inhibited. Interestingly, a PI3K inhibitor, LY294002, and an Akt inhibitor, UCN-01 (7-hydroxystaurosporine), both synergistically sensitized U87-MG and T98G cells as well as U373-MG cells to rapamycin by stimulating the induction of autophagy. Enforced expression of active Akt in tumor cells suppressed the combined effects of LY294002 or UCN-01, whereas dominant-negative Akt expression was sufficient to increase the sensitivity of tumor cells to rapamycin. These results indicate that rapamycin exerts its antitumor effect on malignant glioma cells by inducing autophagy and suggest that in malignant glioma cells a disruption of the PI3K/Akt signaling pathway could greatly enhance the effectiveness of mTOR inhibitors.
Similar articles
-
Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition.Cancer Res. 2005 Aug 15;65(16):7052-8. doi: 10.1158/0008-5472.CAN-05-0917. Cancer Res. 2005. PMID: 16103051
-
Akt inhibitor shows anticancer and radiosensitizing effects in malignant glioma cells by inducing autophagy.Int J Oncol. 2007 Oct;31(4):753-60. Int J Oncol. 2007. PMID: 17786305
-
PKB/Akt mediates radiosensitization by the signaling inhibitor LY294002 in human malignant gliomas.J Neurooncol. 2005 Feb;71(3):215-22. doi: 10.1007/s11060-004-1718-y. J Neurooncol. 2005. PMID: 15735908
-
New inhibitors of the PI3K-Akt-mTOR pathway: insights into mTOR signaling from a new generation of Tor Kinase Domain Inhibitors (TORKinibs).Curr Top Microbiol Immunol. 2010;347:241-62. doi: 10.1007/82_2010_64. Curr Top Microbiol Immunol. 2010. PMID: 20549474 Review.
-
New targets for therapy in breast cancer: mammalian target of rapamycin (mTOR) antagonists.Breast Cancer Res. 2004;6(5):219-24. doi: 10.1186/bcr927. Epub 2004 Aug 12. Breast Cancer Res. 2004. PMID: 15318929 Free PMC article. Review.
Cited by
-
The multiple roles of autophagy in uveal melanoma and the microenvironment.J Cancer Res Clin Oncol. 2024 Mar 11;150(3):121. doi: 10.1007/s00432-023-05576-3. J Cancer Res Clin Oncol. 2024. PMID: 38467935 Free PMC article. Review.
-
Migrasomal autophagosomes relieve endoplasmic reticulum stress in glioblastoma cells.BMC Biol. 2024 Jan 30;22(1):23. doi: 10.1186/s12915-024-01829-w. BMC Biol. 2024. PMID: 38287397 Free PMC article.
-
Autophagy Modulation and Its Implications on Glioblastoma Treatment.Curr Issues Mol Biol. 2023 Oct 29;45(11):8687-8703. doi: 10.3390/cimb45110546. Curr Issues Mol Biol. 2023. PMID: 37998723 Free PMC article. Review.
-
The role of miRNAs in Behçet's disease.Front Immunol. 2023 Oct 4;14:1249826. doi: 10.3389/fimmu.2023.1249826. eCollection 2023. Front Immunol. 2023. PMID: 37860009 Free PMC article. Review.
-
Nuciferine induces autophagy to relieve vascular cell adhesion molecule 1 activation via repressing the Akt/mTOR/AP1 signal pathway in the vascular endothelium.Front Pharmacol. 2023 Sep 28;14:1264324. doi: 10.3389/fphar.2023.1264324. eCollection 2023. Front Pharmacol. 2023. PMID: 37841916 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous